KING Igraine plc

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED ("MAR"). ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE ("RIS"), THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Igraine plc

AQSE: KING

("Igraine" or "the Company")

Total Voting Rights

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the Company hereby announces that as at 31 January 2025 there were 122,021,622 ordinary shares of 0.002p in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 122,021,622.

The above figure of 122,021,622 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Enquiries

Company:

David Levis (Chief Executive Officer)

David@igraineplc.com

Simon Grant-Rennick (Non-Executive Chairman)

Simon@igraineplc.com

Steve Winfield (Non-Executive Director)

Steve@igraineplc.com

Investor relations : info@igraineplc.com

AQSE Growth Market Corporate Adviser:

Peterhouse Capital Limited

Tel: +44 (0) 207 469 0930